SEC Form 4 · accession 0001209191-18-008290
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sandra L. Morgan
Officer — SVP-Provider Relations
Period of report
Feb 5, 2018
Accepted (ET)
Feb 7, 2018 · 8:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 5, 2018 | M | 500 | — | A | 5,410 | D | |
| Common Stock | Feb 5, 2018 | F | 149 | $95.89 | D | 5,261 | D | |
| Common StockF2 | Feb 6, 2018 | S | 3,698 | $96.9075 | D | 1,563 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | — | Feb 5, 2018 | M | 500 | D | Feb 5, 2018 | Feb 5, 2024 | Common Stock | 500 | 0 | D |
Explanation of responses
- F1Restricted stock units convert into common stock on a one-for-one basis.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.9064 to $96.92, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.